org placeholder image

Cyril Empig

Lead, Non-Clinical Studies at Uvax Bio

  • LinkedIn

Email Email: c****@uvaxbio.com

phone noPhone Number: (***)-***-****

map
UVAX BIO

UVAX BIO

  • Headquarter Headquarters: 660 W Germantown Pike, Newark, Delaware, 19462, United States
  • Industry Industry Biotechnology
  • website Website uvaxbio.com
  • description Description
    Founded in early 2018, Uvax Bio, a spin-off vaccine company from Scripps Research, La Jolla, CA, employs patented single-component self-assembling protein nanoparticle (1c-SApNP) platform tec...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 250 Million to 500 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Uvax Bio Org Chart and Mapping

Employees

Benjamin Wang

Business Development Associate

Cyril Empig

Lead, Non-Clinical Studies

Matthijs Schoots

Chief of Staff, Head Strategic Planning

Kevin O'Neill

Senior Vice President, Corporate Strategy

Ke Li

Vice President, Vaccine Development and Technical Ops

Frequently Asked Questions Regarding Cyril Empig

Answer: Cyril Empig works for Uvax Bio as Lead, Non-Clinical Studies

Answer: Cyril Empig’s role in Uvax Bio is Lead, Non-Clinical Studies

Answer: Cyril Empig's email address is c***@gmail.com

Answer: Cyril Empig's business email address is c****@uvaxbio.com

Answer: Cyril Empig’s direct phone number is (***)-***-****

Answer: Cyril Empig works in the industry of: Biotechnology

Answer: Cyril Empig works Uvax Bio located at 660 W Germantown Pike, Newark, Delaware, 19462, United States

Answer: Uvax Bio's Lead, Non-Clinical Studies is Cyril Empig

Answer: Cyril Empig contact details:

  • Phone number  :  (***)-***-****
  • Email  :  c****@uvaxbio.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access